Joyn Bio
Boston
About Joyn Bio
Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2017)
- Website: joynbio.com
- Phone: [email protected]
Industries & Categories
Agriculture, Biotechnology, Environmental Consulting, Health Care
Social Profiles
Canonical: https://fsome.com/organization/joyn-bio-81002 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.